Lupin gets FDA blessing for generic Westcort cream

Press enter to search
Close search
Open Menu

Lupin gets FDA blessing for generic Westcort cream

By Sandra Levy - 08/21/2019
Lupin has received the Food and Drug Administration’s green light for hydrocortisone valerate cream.

Lupin's product is the generic version of Sun Pharmaceuticals’ Westcort cream, 0.2%.

It is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in adult patients.

Hydrocortisone valerate cream had a market value of approximately $15 million, according to March 2019 IQVIA data.

RELATED TOPICS